Surgical revascularization versus best endovascular therapy for chronic limb-threatening ischemia with infrapopliteal disease.
Autor: | Kumar A; Department of Internal Medicine, Cleveland Clinic Akron General, 1 Akron General Ave, Akron, OH, USA., Gajanana D; Department of Cardiology, Cleveland Clinic Akron General, 1 Akron General Ave, Akron, OH, USA., Sharma N; Department of Cardiology, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA., Nanjundappa A; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA., Kalra A; Department of Cardiology, Franciscan Health, 3900 St. Francis Way, Suite 200, Lafayette, IN, USA. Electronic address: akalra@alumni.harvard.edu. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Apr; Vol. 61, pp. 111-112. Date of Electronic Publication: 2023 Nov 02. |
DOI: | 10.1016/j.carrev.2023.11.001 |
Abstrakt: | Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
Databáze: | MEDLINE |
Externí odkaz: |